Kanada - inglise - Health Canada

cheplapharm arzneimittel gmbh - clonazepam - tablet - 0.5mg - clonazepam 0.5mg - benzodiazepines

Kanada - inglise - Health Canada

cheplapharm arzneimittel gmbh - clonazepam - tablet - 2mg - clonazepam 2mg - benzodiazepines

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

pharmaco australia ltd - clonazepam, quantity: 1 mg - diluent, not applicable - excipient ingredients: water for injections - injection: intravenous use, for status epilepticus.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - clonazepam 1 mg/ml - injection with diluent - 1 mg - active: clonazepam 1 mg/ml excipient: benzyl alcohol ethanol glacial acetic acid propylene glycol water for injection - most clinical forms of epilepsy in infants and children, in particular typical and atypical absences (lennox-gastaut syndrome), nodding spasms, primary or secondary generalised tonic-clonic seizures. in adults, rivotril may be used in all varieties of generalised epilepsy (including absence, myoclonic, akinetic, tonic and tonic-clonic seizures), and in partial (focal) epilepsy (including psychomotor seizures).

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - clonazepam 2.5 mg/ml; clonazepam 2.5 mg/ml - oral solution - 2.5 mg/ml - active: clonazepam 2.5 mg/ml excipient: acetic acid peach flavour phl-014725 propylene glycol saccharin sodium active: clonazepam 2.5 mg/ml excipient: acetic acid brilliant blue fcf peach flavour phl-014725 propylene glycol saccharin sodium - most clinical forms of epilepsy in infants and children, in particular typical and atypical absences (lennox-gastaut syndrome), nodding spasms, primary or secondary generalised tonic-clonic seizures. in adults, rivotril may be used in all varieties of generalised epilepsy (including absence, myoclonic, akinetic, tonic and tonic-clonic seizures), and in partial (focal) epilepsy (including psychomotor seizures).

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 250 microgram - tablet, uncoated - excipient ingredients: magnesium stearate; rice starch; lactose monohydrate; oxidised maize starch; hydrolysed maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 0.0625 microgram - tablet, uncoated - excipient ingredients: lactose monohydrate; rice starch; magnesium stearate; hydrolysed maize starch; povidone; indigo carmine; oxidised maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - dienogest, quantity: 2 mg - tablet - excipient ingredients: crospovidone; purified talc; microcrystalline cellulose; povidone; potato starch; lactose monohydrate; magnesium stearate - treatment of endometriosis

Singapur - inglise - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - amlodipine besylate 13.87mg (corresponds to amlodipine base); valsartan - tablet, film coated - 10.0mg - amlodipine besylate 13.87mg (corresponds to amlodipine base) 10.0mg; valsartan 160.0mg

Singapur - inglise - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - amlodipine besylate 6.94mg (corresponds to amlodipine base); valsartan - tablet, film coated - 5mg - amlodipine besylate 6.94mg (corresponds to amlodipine base) 5mg; valsartan 160.0mg